In a cohort of 139 patients with biopsy-proved NAFLD compared to 155 healthy controls, CK-18 fragments levels independently predicted the presence of NASH (AUC 0.83) with a sensitivity of 0.75 and specificity of 0.9 [33]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.